You just read:

EnGeneIC and Asbestos Diseases Research Institute Announce Encouraging Results from MesomiR-1 Phase 1 Trial in Late Stage Mesothelioma patients

News provided by

EnGeneIC, Ltd.

Jun 15, 2015, 08:10 ET